Arcus Biosciences, Inc.
(NYSE : RCUS)

( )
RCUS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.79%175.450.0%$1652.17m
NVAXNovavax, Inc. 2.89%95.0078.2%$651.63m
AMGNAmgen, Inc. 0.03%231.371.4%$520.49m
BIIBBiogen, Inc. 0.00%230.811.8%$499.50m
GILDGilead Sciences, Inc. 0.03%69.091.0%$465.92m
BNTXBioNTech SE 2.33%165.420.0%$448.77m
REGNRegeneron Pharmaceuticals, Inc. 0.00%618.112.7%$392.67m
ILMNIllumina, Inc. 0.95%388.003.3%$389.74m
VRTXVertex Pharmaceuticals, Inc. 0.26%231.431.9%$335.21m
SNSSSunesis Pharmaceuticals, Inc. 0.00%2.880.7%$201.32m
EXASEXACT Sciences Corp. 0.30%76.3617.9%$161.13m
ARNAArena Pharmaceuticals, Inc. 0.00%91.5113.7%$138.71m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%138.628.2%$131.51m
INCYIncyte Corp. 0.00%74.782.4%$129.60m
BBIOBridgeBio Pharma, Inc. 0.00%11.700.0%$104.26m

Company Profile

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.